Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,519 | -59,685 | -58,388 | -42,853 | -49,967 |
| Depreciation Amortization | 105 | 92 | 89 | 93 | 97 |
| Other Working Capital | 3,656 | 1,243 | -3,262 | 2,257 | -5,807 |
| Other Operating Activity | 8,910 | 11,926 | 9,092 | 7,279 | 4,945 |
| Operating Cash Flow | $-28,848 | $-46,424 | $-52,469 | $-33,224 | $-50,732 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,316 | 4,868 | -56,852 | 70,000 | -70,000 |
| PPE Investments | -33 | -112 | -272 | N/A | N/A |
| Investing Cash Flow | $8,283 | $4,756 | $-57,124 | $70,000 | $-70,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50,000 | N/A | N/A | N/A |
| Common Stock Issued | 32,119 | 574 | 3,088 | 5,055 | 73,224 |
| Other Financing Activity | 0 | -2,782 | 0 | 0 | 0 |
| Financing Cash Flow | $32,119 | $47,792 | $3,088 | $5,055 | $73,224 |
| Beginning Cash Position | 13,760 | 7,636 | 114,141 | 72,310 | 119,818 |
| End Cash Position | 25,314 | 13,760 | 7,636 | 114,141 | 72,310 |
| Net Cash Flow | $11,554 | $6,124 | $-106,505 | $41,831 | $-47,508 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,848 | -46,424 | -52,469 | -33,224 | -50,732 |
| Capital Expenditure | -33 | -112 | -272 | N/A | N/A |
| Free Cash Flow | -28,881 | -46,536 | -52,741 | -33,224 | -50,732 |